Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Developing advanced blood-brain barrier permeability imaging for early AD

    Aging is the primary risk factor in aging-related dementia. An important initiating factor for the development and progression of cognitive impairment is disruption of the ...

    View Details

  • NMTRC14: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

    If you or your child have been diagnosed with neuroblastoma that is now in remission, you or your child may be qualified to participate in ...

    View Details

  • NYU Diabetes Biobank and Database

    We are looking for participants with a diagnosis of diabetes or with a brother or sister with diabetes. The purpose of this study is to ...

    View Details

  • A single-center observational study of the prevalence and characteristics of clutter and hoarding disorder in an MS population

    The purpose of this study is to determine the prevalence of hoarding or cluttering in individuals with Multiple Sclerosis (MS), and to determine if this ...

    View Details

  • Relationship between the ocular microbiome and pseudoexfoliation syndrome

    Observational study to determine the microbiome structure of the eye, mouth, and skin of subjects with pseudo exfoliation syndrome and cataracts before and after cataract ...

    View Details

  • Exhaled and nasal nitric oxide in children and adults with chronic wet cough

    The purpose of this study is to see if we can use non-invasive tests called forced exhaled nitric oxide (FeNO) (a reading that we get ...

    View Details

  • A Phase 2 multicenter randomized double-blind placebo-controlled study to assess the efficacy safety and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of neurobehavioral disinhibition including aggression agitation and irritability in patients with traumatic brain injury (TBI)

    Symptoms associated with TBI such as physical and verbal aggression, agitation and irritability are problematic, can be difficult to manage, can be disruptive, and can ...

    View Details

  • A phase II study of lenvatinib a multi-targeted tyrosine kinase inhibitor combined with pembrolizumab (PD-1 inhibitor) for the treatment of metastatic gastroesophageal cancer patients who have progressed on first or subsequent line therapies

    If you have been diagnosed with gastroesophageal, stomach, or gastroesophageal junction (GEJ) cancers, you may qualify for this clinical trial. The goal of this phase ...

    View Details